As pancreatic cancer survival is associated with other attributable risk factors, such as stage, age and gender44, we evaluated the prognostic efficacy of STAT3 compared to the prognostic value of these clinical variables. This evidence concerns the gene STAT3 and pancreatic neoplasm.